Company intelligence / Profile preview
Omniox
San Carlos, California, United Statesomniox.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Omniox has developed a proprietary H-NOX protein platform to create stable biologic oxygen carriers designed to deliver oxygen directly to hypoxic tissues. This approach aims to address unmet needs in diseases where low tissue oxygen contributes significantly to pathology—such as cancer and cardiovascular conditions. The company’s lead programs are at the IND/preclinical/early clinical interface. No published late-stage clinical results are available yet.
- Therapeutic areas
- OncologyPulmonologyCardiovascular
- Modalities
- Protein therapeuticsoxygen delivery biologics
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Omniox.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omniox.